ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CING Cingulate Inc

0.8741
0.00 (0.00%)
Pre Market
Last Updated: 04:54:14
Delayed by 15 minutes

Period:

Draw Mode:

Volume 378
Bid Price 0.84
Ask Price 0.943
News -
Day High

Low
0.75

52 Week Range

High
23.40

Day Low
Company Name Stock Ticker Symbol Market Type
Cingulate Inc CING NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.8741 04:54:14
Open Price Low Price High Price Close Price Prev Close
0.8741
Trades Volume Avg Volume 52 Week Range
4 378 - 0.75 - 23.40
Last Trade Time Type Quantity Stock Price Currency
04:54:14 formt 117 $ 0.8741 USD

Cingulate Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
815.19k 937.00k - 0 -23.54M -25.12 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cingulate News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CING Message Board. Create One! See More Posts on CING Message Board See More Message Board Posts

Historical CING Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.8860.92990.82740.861366728,801-0.0119-1.34%
1 Month1.061.14940.750.939518596,878-0.1859-17.54%
3 Months1.281.500.751.15213,404-0.4059-31.71%
6 Months8.5412.700.755.21904,662-7.67-89.76%
1 Year21.4023.400.757.68599,186-20.53-95.92%
3 Years100.00103.000.7519.05411,673-99.13-99.13%
5 Years100.00103.000.7519.05411,673-99.13-99.13%

Cingulate Description

Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.

Your Recent History

Delayed Upgrade Clock